Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients

Summary

KI1001(Circadin®, Prolonged release tablet which contains melatonin) has showed its efficacy to improve sleep quality in over 55 years old primary insomnia patients. This is a 2nd bridging study to investigate the efficacy and safety of KI1001(Circadin®) in Korean patients.

Timeline

Start

2013-08

Primary completion

2014-01

Completion

2014-01

Drugs

Indications